Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
- Resource Type
- Source
- The Lancet Gastroenterology & Hepatology. 8:511-522
- Subject
Hepatology Gastroenterology - Language
- ISSN
- 2468-1253